HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Extracorporeal SWL in the treatment of reno-ureteral calculosis in day hospital].

Abstract
Eighteen years after the first clinical shock wave lithotripsy (SWL), no doubt remains as to its therapeutic efficacy in ureterorenal lithiasis. The advent of lithotriptors with a large shock wave energy range and integration of both ultrasound and radiologic imaging equipment at the shock wave source has meant that outpatients treatment of urolithiasis is now feasible in a good proportion of cases. In our lithotripsy center, from January 1995 to August 1996, 208 out of 310 patients who underwent SWL treatment for renal and ureteral stones, were outpatients. Pretreatment manoeuvres were performed in 10.6% of the patients. No major complications occurred during the treatment. Only three patients (1.4%) were admitted to hospital because of fever, colics or perirenal haematoma in the first two days after SWL therapy. The stone free rate was 67 and 84% respectively one and three months after treatment. In our experience, the possibility of performing SWL treatments without anesthesia and even analgosedation, the absence of complications and the high success rate, make outpatient treatment of urolithiasis safe and suitable in a large number of patients.
AuthorsG Zanetti, I Kartalas Goumas, F Rovera, F Ostini, A Guarneri, S Stagni, E Montanari, A Trincheri
JournalArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica (Arch Ital Urol Androl) Vol. 70 Issue 3 Pg. 153-7 (Jun 1998) ISSN: 1124-3562 [Print] Italy
Vernacular TitleTrattamento extracorporeo SWL della calcolosi reno-ureterale (SWL) in Day Hospital.
PMID9738320 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care
  • Female
  • Hospitalization
  • Humans
  • Kidney Calculi (therapy)
  • Lithotripsy (adverse effects)
  • Male
  • Middle Aged
  • Ureteral Calculi (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: